Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Question added to shareholder forum

If PDS goes Chapter 7, do this null and void our Com Ag with TPL and then we once again gain control of the licensing ability on our own?

Share
New Message
Please login to post a reply